Bausch Health Companies Inc News - BVF

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bausch Health Companies Inc (BVF)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BVF News

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

Biovail Provides 2004 Guidance

Biovail Reports Third Quarter 2003 Financial Results

Re: Interim Report

Re: Removal of the Shares etc

BVF Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bausch Health Companies Inc (BVF) News

Bausch Health Companies Inc (BVF)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

BVF News

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

Biovail Provides 2004 Guidance

Biovail Reports Third Quarter 2003 Financial Results

Re: Interim Report

Re: Removal of the Shares etc

BVF Discussion

Your Recent History